Skip to main content
Fig. 1 | Lipids in Health and Disease

Fig. 1

From: Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastases

Fig. 1

LysoPC removal and FA incorporation by solid tumour cells and leukaemic cells. a: Removal of exogenously added LysoPC 17:0 (450 μM) in cell culture supernatants of solid tumour cells (n = 3 measurements). b: Time course of cellular FA C17:0 ratio of LysoPC 17:0 treated solid tumour cells (450 μM). c: Time course of the degradation of LysoPC 17:0 (450 μM) from cell culture supernatant of leukaemic cells (n = 6 measurements). d: Incorporation of FA C17:0 into cellular lipids due to LysoPC treatment of leukaemic cells (n = 3 measurements). Changes in FA C17:0 contents are shown in % of total FA in time course experiments

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X